Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-11

Clinical Trial Update: A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes [NA]

View source ↗

Summary

A single-arm feasibility study evaluating GlycoLeap, an online lifestyle modification and self-management program for Type 2 Diabetes, has completed recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GlycoLeap

Snippet

Sponsor: Duke-NUS Graduate Medical School | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED